Dr. Sahdeo Prasad has joined Department of Biotechnology and Immunotherapeutics, Texas Tech University as a Research Instructor. Dr. Prasad has obtained his Ph.D. (Biotechnology), CSJM University, Kanpur, India and Indian Institute of Toxicology Research (CSIR), Lucknow, India collaboratively. During doctoral research program, he extensively worked on signal transduction pathways in both in vivo and in vitro tumor models. Dr. Prasad received National Eligibility Test (CSIR - UGC-NET), Graduate Aptitude Test in Engineering (GATE) and Indian Council of Medical Research Junior Research Fellowship award (ICMR-JRF) by Govt. of India during his Master program. Before joining Department of Biotechnology and Immunotherapeutics, he worked as Post - Doctoral Fellow in Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center and in Department of Pharmacology, University of Pittsburgh, PA. His expertise is in the area of molecular biology with particular reference to molecular mechanisms of signal transduction in tumor cells. Dr. Prasad has discovered a number of phytochemicals with chemo-preventive effects against a variety of cancers and their mechanism of action. Besides these, Dr. Prasad’s work is also focused on the effect of natural compounds on death receptor pathways, bone loss and chemosensitization of tumor cells. The current research focus of Dr. Prasad is identification of novel drug as a chemo-preventive and chemotherapeutic agents that could suppress the activation of transcription factors, kinases and oncogenes. His research area also include to explore the efficacy of novel drugs in vivo in preclinical experiments with suitable animal models and to verify changes in surrogate biomarkers. He has numerous National and International publications, abstracts Indexed in International conferences. He is also an editorial board member of various reputed journals and member of various scientific societies.